Anupam Das, Abhishek De, Kiran Godse, Prabhakar Sangolli, Vijay Zawar, Nidhi Sharma, Mukesh Girdhar, Indrashis Podder, Bela Shah, Sandipan Dhar
There is a dearth of data regarding the safety and timing of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination of patients on immunosuppressive or immunomodulatory therapies. However, data from other vaccine trials may be extrapolated to get an idea regarding the recommendation of SARS-COV-2 vaccines. All the novel SARS-COV-2 vaccines are non-live, thus ensuring the safety of the vaccines. However, the vaccines may not be able to generate an equipotent immunogenic response in patients receiving immunotherapeutics, in comparison to those who are not...
May 2022: Indian Journal of Dermatology